162 related articles for article (PubMed ID: 32235738)
21. LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.
Tu Y; Sánchez-Iglesias S; Araújo-Vilar D; Fong LG; Young SG
Nucleus; 2016 Sep; 7(5):512-521. PubMed ID: 27841971
[TBL] [Abstract][Full Text] [Related]
22. Prelamin A processing, accumulation and distribution in normal cells and laminopathy disorders.
Casasola A; Scalzo D; Nandakumar V; Halow J; Recillas-Targa F; Groudine M; Rincón-Arano H
Nucleus; 2016; 7(1):84-102. PubMed ID: 26900797
[TBL] [Abstract][Full Text] [Related]
23. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail.
Wang Z; Chen X; Zhao Y; Jin Y; Zheng J
J Cancer Res Clin Oncol; 2019 Jan; 145(1):87-96. PubMed ID: 30341688
[TBL] [Abstract][Full Text] [Related]
24. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome.
Gruber J; Lampe T; Osborn M; Weber K
J Cell Sci; 2005 Feb; 118(Pt 4):689-96. PubMed ID: 15671064
[TBL] [Abstract][Full Text] [Related]
25. Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.
Zou J; Zhang W; Li XL
Calcif Tissue Int; 2017 Jun; 100(6):551-564. PubMed ID: 28246931
[TBL] [Abstract][Full Text] [Related]
26. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
27. MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.
Wang D; Tang L; Wu H; Wang K; Gu D
IUBMB Life; 2018 May; 70(5):411-419. PubMed ID: 29573114
[TBL] [Abstract][Full Text] [Related]
28. Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation.
Constantinescu D; Gray HL; Sammak PJ; Schatten GP; Csoka AB
Stem Cells; 2006 Jan; 24(1):177-85. PubMed ID: 16179429
[TBL] [Abstract][Full Text] [Related]
29. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-449b-5p Suppresses Proliferation, Migration, and Invasion of Osteosarcoma by Targeting c-Met.
Li Q; Lu C; Wang J; Gao M; Gao W
Med Sci Monit; 2019 Aug; 25():6236-6243. PubMed ID: 31425497
[TBL] [Abstract][Full Text] [Related]
31. The effect of the lamin A and its mutants on nuclear structure, cell proliferation, protein stability, and mobility in embryonic cells.
Piekarowicz K; Machowska M; Dratkiewicz E; Lorek D; Madej-Pilarczyk A; Rzepecki R
Chromosoma; 2017 Aug; 126(4):501-517. PubMed ID: 27534416
[TBL] [Abstract][Full Text] [Related]
32. CNOT1 cooperates with LMNA to aggravate osteosarcoma tumorigenesis through the Hedgehog signaling pathway.
Cheng DD; Li J; Li SJ; Yang QC; Fan CY
Mol Oncol; 2017 Apr; 11(4):388-404. PubMed ID: 28188704
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells.
Salvatori L; Caporuscio F; Coroniti G; Starace G; Frati L; Russo MA; Petrangeli E
J Cell Physiol; 2009 Jul; 220(1):35-44. PubMed ID: 19347870
[TBL] [Abstract][Full Text] [Related]
34. miR-33a Mediates the Anti-Tumor Effect of Lovastatin in Osteosarcoma by Targeting CYR61.
Huang Y; Zhang J; Shao H; Liu J; Jin M; Chen J; Zhao H
Cell Physiol Biochem; 2018; 51(2):938-948. PubMed ID: 30466075
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
36. Modulation of LMNA splicing as a strategy to treat prelamin A diseases.
Lee JM; Nobumori C; Tu Y; Choi C; Yang SH; Jung HJ; Vickers TA; Rigo F; Bennett CF; Young SG; Fong LG
J Clin Invest; 2016 Apr; 126(4):1592-602. PubMed ID: 26999604
[TBL] [Abstract][Full Text] [Related]
37. Sustained release of vitamin C from PCL coated TCP induces proliferation and differentiation of osteoblast cells and suppresses osteosarcoma cell growth.
Bose S; Sarkar N; Vahabzadeh S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110096. PubMed ID: 31546344
[TBL] [Abstract][Full Text] [Related]
38. Chalcone Derivatives 4'-Amino-1-Naphthyl-Chalcone (D14) and 4'-Amino-4-Methyl-1-Naphthyl-Chalcone (D15) Suppress Migration and Invasion of Osteosarcoma Cells Mediated by p53 Regulating EMT-Related Genes.
Seba V; Silva G; Santos MBD; Baek SJ; França SC; Fachin AL; Regasini LO; Marins M
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235848
[TBL] [Abstract][Full Text] [Related]
39. Lamin A/C Acts as an Essential Factor in Mesenchymal Stem Cell Differentiation Through the Regulation of the Dynamics of the Wnt/β-Catenin Pathway.
Bermeo S; Vidal C; Zhou H; Duque G
J Cell Biochem; 2015 Oct; 116(10):2344-53. PubMed ID: 25846419
[TBL] [Abstract][Full Text] [Related]
40. PTEN Plays Dual Roles As a Tumor Suppressor in Osteosarcoma Cells.
Xi Y; Chen Y
J Cell Biochem; 2017 Sep; 118(9):2684-2692. PubMed ID: 28106296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]